BioStem Technologies, Inc. (OTCMKTS:BSEM - Get Free Report) saw a significant decrease in short interest in the month of April. As of April 15th, there was short interest totalling 129,500 shares, a decrease of 23.9% from the March 31st total of 170,200 shares. Approximately 0.8% of the company's stock are short sold. Based on an average daily trading volume, of 186,300 shares, the short-interest ratio is presently 0.7 days.
BioStem Technologies Trading Down 1.0 %
BSEM traded down $0.14 during trading hours on Tuesday, hitting $13.89. The company's stock had a trading volume of 54,917 shares, compared to its average volume of 67,078. The firm has a market capitalization of $232.00 million, a PE ratio of 20.43 and a beta of -0.10. The company has a 50-day simple moving average of $11.09 and a 200 day simple moving average of $13.94. BioStem Technologies has a fifty-two week low of $6.77 and a fifty-two week high of $28.26.
BioStem Technologies Company Profile
(
Get Free Report)
BioStem Technologies, Inc, a life sciences corporation, focuses on discovering, developing, and producing pharmaceutical and regenerative medicine products and services. It develops various biologic stem cell based alternative products, as a treatment for ailments, such as joint pain, tendon and ligament injuries, neurodegenerative, and autoimmune diseases.
Featured Articles
Before you consider BioStem Technologies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and BioStem Technologies wasn't on the list.
While BioStem Technologies currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.